Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 1/20 | 0.41 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.39 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | PPARD | Q03181 | 1/20 | 0.38 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.38 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ADH1B | P00325 | 1/20 | 0.36 |
| ▸ | ADH1C | P00326 | 1/20 | 0.36 |
| ▸ | ADH1A | P07327 | 1/20 | 0.36 |
| ▸ | ADH4 | P08319 | 1/20 | 0.36 |
| ▸ | ADH7 | P40394 | 1/20 | 0.36 |
| ▸ | THRB | P10828 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.34 |
| ▸ | FDPS | P14324 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Ammonia Solution, Strong SCHEMBL8363598 | 1.00 | OPRM1 (0.41) | OPRM1SPHK1LMNALCKPPARD | |
| Ammonia Solution, Strong SCHEMBL1344181 | 1.00 | OPRM1 (0.41) | OPRM1SPHK1LMNALCKPPARD | |
| Ammonia Solution, Strong SCHEMBL2110651 | 1.00 | OPRM1 (0.41) | OPRM1SPHK1LMNALCKPPARD | |
| Ammonia Solution, Strong SCHEMBL9803720 | 1.00 | OPRM1 (0.41) | OPRM1SPHK1LMNALCKPPARD | |
| Ammonia Solution, Strong SCHEMBL3952379 | 1.00 | OPRM1 (0.41) | OPRM1SPHK1LMNALCKPPARD | |
| SCHEMBL27867791 | 0.98 | OPRM1 (0.42) | OPRM1SPHK1LMNALCKPPARD | |
| Phosphine SCHEMBL28272934 | 0.95 | OPRM1 (0.41) | OPRM1SPHK1LMNALCKPPARD | |
| Trimethylammonium SCHEMBL28424587 | 0.91 | OPRM1 (0.38) | OPRM1SPHK1LMNALCKPPARD | |
| Ammonia Solution, Strong SCHEMBL7236156 | 0.83 | OPRM1 (0.38) | OPRM1SPHK1LMNALCKPPARD | |
| Ammonia Solution, Strong SCHEMBL27986318 | 0.82 | OPRM1 (0.46) | OPRM1SPHK1LMNADNM1TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024008014-A1 | PHARMACEUTICAL COMPOSITION FOR RESISTING INFECTION WITH SARS-COV-2 OR MUTANT THEREOF, AND COMBINED DRUG THEREOF | 成都威斯克生物医药有限公司 | 2024-01-11 | — | — | WO | claimed |
| CN-115531617-B | Gastrostomy catheter coated with lipopolysaccharide compound | 上海市徐汇区大华医院 | 2023-09-29 | — | — | CN | claimed |
| CN-115414536-A | Gene elution balloon and preparation method and application thereof | 苏州中天医疗器械科技有限公司 | 2022-12-02 | — | — | CN | claimed |
| US-20190350200-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITIONS | JUBILANT LIFE SCIENCES LIMITED (IN) | 2019-11-21 | — | — | US | claimed |
| EP-3534708-A1 | SYNERGISTIC ANTIMICROBIAL COMPOSITIONS | Jubilant Life Sciences Limited (IN) | 2019-09-11 | — | — | EP | claimed |
| US-20150313846-A1 | PROLONGED-RELEASE MULTIMICROPARTICULATE ORAL PHARMACEUTICAL FORM | FLAMEL IRELAND LIMITED (IE) | 2015-11-05 | — | — | US | claimed |
| CN-119970640-A | Novel nucleic acid delivery system based on phosphatidylmitoxantrone and preparation method and application thereof | 华东理工大学 | 2025-05-13 | — | — | CN | disclosed |
| CN-116004728-B | Polymer-coated lipid nanoparticle, preparation method thereof and pharmaceutical preparation | 深圳大学总医院 | 2025-02-28 | — | — | CN | disclosed |
| WO-2024193380-A1 | VACCINE AGAINST RESPIRATORY SYNCYTIAL VIRUS INFECTION | 成都威斯克生物医药有限公司 | 2024-09-26 | — | — | WO | disclosed |
| WO-2024138921-A1 | NON-HEPATIC TARGETING NUCLEIC ACID NANO-FORMULATION, PREPARATION METHOD THEREFOR, AND USE THEREOF | 华南理工大学 | 2024-07-04 | — | — | WO | disclosed |
| CN-114099699-B | Nanometer delivery system and preparation method and application thereof | 华南理工大学 | 2024-03-19 | — | — | CN | disclosed |
| WO-2024008014-A1 | PHARMACEUTICAL COMPOSITION FOR RESISTING INFECTION WITH SARS-COV-2 OR MUTANT THEREOF, AND COMBINED DRUG THEREOF | 成都威斯克生物医药有限公司 | 2024-01-11 | — | — | WO | disclosed |
| CN-115531617-B | Gastrostomy catheter coated with lipopolysaccharide compound | 上海市徐汇区大华医院 | 2023-09-29 | — | — | CN | disclosed |
| US-8697098-B2 | Polymer conjugated protein micelles | SOUTH DAKOTA STATE UNIVERSITY (US) | 2014-04-15 | — | — | US | disclosed |
| EP-2678001-A2 | POLYMER CONJUGATED PROTEIN MICELLES | South Dakota State University (US) | 2014-01-01 | — | — | EP | disclosed |
| WO-2013188740-A1 | ANTI-PSMA ANTIBODIES CONJUGATED TO NUCLEAR RECEPTOR LIGAND POLYPEPTIDES | AMBRX, INC. (US) | 2013-12-19 | — | — | WO | disclosed |
| US-20120219600-A1 | POLYMER CONJUGATED PROTEIN MICELLES | SOUTH DAKOTA STATE UNIVERSITY | 2012-08-30 | — | — | US | disclosed |
| WO-2012116272-A2 | POLYMER CONJUGATED PROTEIN MICELLES | SOUTH DAKOTA STATE UNIVERSITY (US) | 2012-08-30 | — | — | WO | disclosed |
| EP-1480679-A1 | PHARMACEUTICAL FORMULATION OF IRESSA COMPRISING A WATER-SOLUBLE CELLULOSE DERIVATIVE | Astrazeneca AB (SE) | 2004-12-01 | — | — | EP | disclosed |
| WO-2003072139-A1 | PHARMACEUTICAL FORMULATION OF IRESSA COMPRISING A WATER-SOLUBLE CELLULOSE DERIVATIVE | ASTRAZENECA AB (SE) | 2003-09-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120219600-A1 | POLYMER CONJUGATED PROTEIN MICELLES | MTDH, PSMG3, GHITM | OPRM1 2781/4885SPHK1 3769/4885LMNA 1032/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.